Patent · US Active

Formulation, apparatus, and methods for treatment of brain trauma

US10130657B2 · kind B2 · utility

0Cited by
3References
19Claims
0Family size

Inventor

Key dates

Filing dateFeb 14, 2016
Grant dateNov 20, 2018
Priority date—
Expiry dateFeb 14, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N5/067
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A formulation comprising platelet rich plasma (PRP) for treatment of patients who have experienced brain injury, consisting of a mixture of human autologous plasma, D5W, glutathione, methylcobalamin, and regular insulin. The formulation is infused directly adjacent to a patient's brain through the nostrils or nares of the nasal cavity. Treatment using the formulation may be supplemented with one or more therapies including hyperbaric oxidation therapy (HBOT), cranial osteopathic therapy, intravenous (IV) nutrition, electroencephalographic (EEG) biofeedback, low level laser therapy (LLLT), transcranial magnetic stimulation (TMS), adult stem cell treatments, and a ketogenic diet and medium-chain triglyceride (MCT) oil therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.